MLNT - Melinta Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Melinta Therapeutics's activity chart (see below) currently has 4 price targets and 4 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 34 days.

Most recent stock forecast was given by from WESTPARK on 12-Aug-2019. First documented stock forecast 11-Sep-2018.

Ed Arce David Hoang

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-Sep-2018

$12

6 years 10 months 28 days ago
(12-Aug-2019)

2/2 (100%)

$-3.4 (-22.08%)

Buy Since 11-Sep-2018

$15

7 years 2 months ago
(10-May-2019)

1/1 (100%)

$-6.75 (-31.03%)

Show more analysts

What is MLNT (Melinta Therapeutics) average time for price targets to be met?

On average it took 34 days on average for the stock forecasts to be realized with a an average price target met ratio 100

Which analyst has the current highest performing score on MLNT (Melinta Therapeutics) with a proven track record?

ED ARCE

Which analyst has the most public recommendations on MLNT (Melinta Therapeutics)?

Ed Arce works at WESTPARK and has 8 price targets and 24 ratings on MLNT

Which analyst is the currently most bullish on MLNT (Melinta Therapeutics)?

David Hoang with highest potential upside - $0

Which analyst is the currently most reserved on MLNT (Melinta Therapeutics)?

David Hoang with lowest potential downside - -$0